TEMPLATE Patient Characteristics LEOSS (Patient Characteristics LEOSS)

TEMPLATE IDPatient Characteristics LEOSS
ConceptPatient Characteristics LEOSS
DescriptionZur Repräsentation der Patienten Charakteristika aus den LEOSS-Datensatz.
PurposeZur Repräsentation der Patienten Charakteristika aus den LEOSS-Datensatz.
References
Other Details (Language Independent)
  • MetaDataSet:Sample Set : Template metadata sample set
Language useden
Citeable Identifier1246.169.792
Root archetype idopenEHR-EHR-COMPOSITION.report.v1
ReportReport: Document to communicate information to others, commonly in response to a request from another party.
Other Context
Identifikator des LaborbefundsIdentifikator des Laborbefunds: Identification information about the report.
StatusStatus: The status of the entire report. Note: This is not the status of any of the report components.
  • Zwischenbefund
  • Endbefund
Case identificationCase identification: To record case identification details for public health purposes.
Case identifierCase identifier: The identifier of this case.
Ethnischer HintergrundEthnischer Hintergrund: Detaillierte Beschreibung des ethnischen Hintergrundes einer Person, um Besondheiten, wie Medikamentenverträglichkeit oder Gesundheitsrisiken abzubilden.
Ethnischer HintergrundEthnischer Hintergrund: Der ethnische Hintergrund einer Person.
  • African & African American
  • American
  • Asian & Pacific Islander
  • Caucasian
  • Hispanic or Latino
  • Unknown
AddressAddress: Address details aligned with FHIR resource.
CountryCountry: Country - a nation as commonly understood or generally accepted.
Demographic InformationDemographic Information: A generic section header which should be renamed in a template to suit a specific clinical context.
AgeAge: Details about the age of an individual.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
AlterskategorieAlterskategorie: Additional narrative about the age of an individual, not captured in other fields.
For example: pre-term delivery
  • <1 year
  • 1-3 years
  • 4-8 years
  • 9-14 years
  • 15-17 years
  • 18-25 years
  • 26-35 years
  • 36-45 years
  • 46-55 years
  • 56-65 years
  • 66-75 years
  • 76-85 years
  • >85 years
GenderGender: Details about the gender of an individual.
Data
Administrative genderAdministrative gender: The gender of an individual used for administrative purposes.
This element is what most systems today describes as 'Sex' or 'Gender'. For example 'Male', 'Female', 'Other'. This aligns with HL7 FHIR 'Person.gender'. Coding with a terminology is recommended, where possible.
  • male
  • female
  • divers
  • not specified
General Information on consultationGeneral Information on consultation: A generic section header which should be renamed in a template to suit a specific clinical context.
Problem/DiagnosisProblem/Diagnosis: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual.
Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'.
Data
Problem/Diagnosis nameProblem/Diagnosis name: Identification of the problem or diagnosis, by name.
Coding of the name of the problem or diagnosis with a terminology is preferred, where possible.
  • COVID-19
Date/time clinically recognisedDate/time clinically recognised: Estimated or actual date/time the diagnosis or problem was recognised by a healthcare professional.
Partial dates are acceptable. If the subject of care is under the age of one year, then the complete date or a minimum of the month and year is necessary to enable accurate age calculations - for example, if used to drive decision support. Data captured/imported as "Age at time of clinical recognition" should be converted to a date using the subject's date of birth.
SeveritySeverity: An assessment of the overall severity of the problem or diagnosis.
If severity is included in the Problem/diagnosis name via precoordinated codes, this data element becomes redundant. Note: more specific grading of severity can be recorded using the Specific details SLOT.
  • Not recovered
  • recovered
  • dead from covid19
  • Dead from other causes
  • Unknown
Date/time of resolutionDate/time of resolution: Estimated or actual date/time of resolution or remission for this problem or diagnosis, as determined by a healthcare professional.
Partial dates are acceptable. If the subject of care is under the age of one year, then the complete date or a minimum of the month and year is necessary to enable accurate age calculations - for example, if used to drive decision support. Data captured/imported as "Age at time of resolution" should be converted to a date using the subject's date of birth.
Protocol
AddressAddress: Address details aligned with FHIR resource.
Region of diagnosisRegion of diagnosis: The name of the administrative area (county).
Postal codePostal code: A postal code designating a region defined by the postal service.
Country of diagnosisCountry of diagnosis: Country - a nation as commonly understood or generally accepted.
ServiceService: A general clinical activity carried out for the patient to receive a specified service, advice or care from an expert healthcare provider.
Description
Service nameService name: Identification of the clinical service to be/being carried out.
Coding of the specific service name with a terminology is preferred, where possible.
  • Consultation
Reason for consultationReason for consultation: Reason that the activity or care pathway step for the identified service was carried out.
For example: the reason for the cancellation or suspension of the service.
Management/treatment screening questionnaireManagement/treatment screening questionnaire: An individual- or self-reported questionnaire screening for management or treatment carried out.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Availability of biomaterialAvailability of biomaterial: The reason for overall screening.
For example: screening for an infectious disease, such as SARS-COV-2.
  • Serum
  • Blood
  • Cells
  • Stool
  • Cerebrospinal fluid
  • other
  • Not done/Unknown
Informed ConsentInformed Consent: Record of status and details of informed consent from a patient (or patient's agent) for a proposed procedure, trial or other healthcare-related activity (including treatments and investigations), based upon a clear appreciation and understanding of the facts, implications, and possible future consequences by the patient or patient's agent.
Description
Procedure/Trial/ActivityProcedure/Trial/Activity: Identification of the procedure, clinical trial or healthcare-related activity (including correct side/correct site, where appropriate) against which the consent status and details are recorded.
  • LEOSS
Consent DescriptionConsent Description: Narrative description of the informed consent required or recorded prior to performing the proposed procedure, clinical trial or healthcare-related activity.
  • Yes, to share data
  • Yes, to share biometarial sample
  • No
  • Unknown
Patient admissionPatient admission: Used for admitted patient only. It signals the beginning of a patient's stay in a health care facility.
Data
Admit sourceAdmit source: Detailed description of the mode of admission.
  • inpatient stay
  • ICU
Admit date/timeAdmit date/time: Date/time the patient was admitted.
Discharge summaryDischarge summary: Used for discharged patient only.
Data
Discharge statusDischarge status: Discharge status.
Discharge date/timeDischarge date/time: Date/Time the patiente was discharge.
Lenght of stayLenght of stay: Lenght of stay on hospital
Units:
  • yr
  • h
  • mo
  • wk
  • d
Stage at diagnosisStage at diagnosis: Comments
  • uncomplicated phase
  • complicated phase
  • critical phase
  • recovery phase
Ventilator observationsVentilator observations: Observation findings returned from ventilator device.
Data
Any eventAny event: *
Data
BeatmungsstundenBeatmungsstunden: Die Beatmungsstunden sind als Gesamtbeatmungszeit für den Krankenhausfall entsprechend DKR anzu-geben.
BeatmungsstundenBeatmungsstunden: Gesamtanzahl der Stunden mit künstlicher Beatmung
>=0 h
Further ConditionsFurther Conditions: A generic section header which should be renamed in a template to suit a specific clinical context.
Ausschluss RauchenAusschluss Rauchen: A statement of exclusion of a specific Problem/diagnosis, Family history, Medication, Procedure, Adverse reaction or other clinical item that is either not currently present, or have not been present in the past.
Data
Adverse reaction substanceAdverse reaction substance: The Adverse reaction substance/agent to which the 'Exclusion statement' applies. For example: 'Penicillin', 'Peanuts' or 'Latex'.
  • Rauchen
Tobacco smoking summaryTobacco smoking summary: Summary or persistent information about the tobacco smoking habits of an individual.
Data
Overall statusOverall status: Statement about current smoking behaviour for all types of tobacco.
  • Current smoker 
  • Former smoker 
Overall descriptionOverall description: Narrative summary about the individual's overall tobacco smoking pattern and history.
Use this data element to record a narrative description of the tobacco smoking habits for this individual or to incorporate unstructured tobacco smoking information from existing or legacy clinical systems into an archetyped format.
  • 1-10 pack years
  • 11-20 pack years
  • > 21 pack years
  • Smoker, unkown
Ausschluss Rauchen e-CigarrettesAusschluss Rauchen e-Cigarrettes: A statement of exclusion of a specific Problem/diagnosis, Family history, Medication, Procedure, Adverse reaction or other clinical item that is either not currently present, or have not been present in the past.
Data
Adverse reaction substanceAdverse reaction substance: The Adverse reaction substance/agent to which the 'Exclusion statement' applies. For example: 'Penicillin', 'Peanuts' or 'Latex'.
  • Rauchen e-Cigarrettes
Zusammenfassung Rauchverhalten e-CigarrettesZusammenfassung Rauchverhalten e-Cigarrettes: Summary or persistent information about the tobacco smoking habits of an individual.
Data
Overall statusOverall status: Statement about current smoking behaviour for all types of tobacco.
  • Current smoker 
Overall descriptionOverall description: Narrative summary about the individual's overall tobacco smoking pattern and history.
Use this data element to record a narrative description of the tobacco smoking habits for this individual or to incorporate unstructured tobacco smoking information from existing or legacy clinical systems into an archetyped format.
  • e-Cigarrettes
Body mass indexBody mass index: Calculated measurement which compares a person's weight and height.
Body Mass Index is a calculated ratio describing how an individual's body weight relates to the weight that is regarded as normal, or desirable, for the individual's height.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Body mass indexBody mass index: Index describing ratio of weight to height.
0..1000; 0..1000
Units:
  • kg/m²
  • [lb_av]/[in_i]2
Immunosuppressive therapy (last 3 months)Immunosuppressive therapy (last 3 months): Questionnaire information about the administration or consumption of any medication, a specified medication or type/class of medication at or during an event such as a specific point in time or duration of time.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific medication classSpecific medication class: Details about the use of a specific class of medication.
Medication class nameMedication class name: Name of class or type of medication.
For example: opioid; or analgesic.
  • Immunosuppressive therapy (last 3 months)
Medication class in use?Medication class in use?: Is the individual using the medication, class or type of medication at or during the identified event?
  • In use 
  • Not in use 
  • Unknown 
Kennzeichnung ErregernachweisKennzeichnung Erregernachweis: Dokumentation eines Nachweis eines Erregers bei einem Patienten.
Data
ErregernachweisErregernachweis: Bei dem Patienten wurde ein Erreger nachgewiesen.
ErregernameErregername: Der Name des nachgewiesenen Erregers bei dem Patienten.
  • None
  • MRSA
  • VRE
  • VRE-LTD
  • 3MGRN
  • 4MRGN
  • Other
  • Unknown
Zeitpunkt der KennzeichnungZeitpunkt der Kennzeichnung: *
Protocol
Zuletzt aktualisiertZuletzt aktualisiert: Datum der letzten Aktualisierung der Diagnose bzw. des Problems.
ComorbiditiesComorbidities: A generic section header which should be renamed in a template to suit a specific clinical context.
Cardiovascular ComorbiditiesCardiovascular Comorbidities: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Coronary artery disease
  • Myocardial infarction
  • Hypertension
  • Atrial fibrillation
  • AV block
  • Aortic stenosis
  • Peripher vascular disease
  • Myocarditis
  • Carotid arterial disease
  • Chronic heart failure
  • Thrombembolic diseases (DVT, PE)
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown 
Problem/Diagnose heart failureProblem/Diagnose heart failure: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual.
Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'.
Data
Problem/Diagnosis nameProblem/Diagnosis name: Identification of the problem or diagnosis, by name.
Coding of the name of the problem or diagnosis with a terminology is preferred, where possible.
  • heart failure
Beschreibung Prior heart failure at diagnosisBeschreibung Prior heart failure at diagnosis: Narrative description about the problem or diagnosis.
Use to provide background and context, including evolution, episodes or exacerbations, progress and any other relevant details, about the problem or diagnosis.
  • None
  • < 1 year
  • 1-5 years
  • > 5 years
  • unknown
Schweregrad Ejection fractionSchweregrad Ejection fraction: An assessment of the overall severity of the problem or diagnosis.
If severity is included in the Problem/diagnosis name via precoordinated codes, this data element becomes redundant. Note: more specific grading of severity can be recorded using the Specific details SLOT.
  • <20%
  • 20-30%
  • 31%-40%
  • 41% -55%
  • > 55 %
  • not done
  • unknown
Date/time of resolutionDate/time of resolution: Estimated or actual date/time of resolution or remission for this problem or diagnosis, as determined by a healthcare professional.
Partial dates are acceptable. If the subject of care is under the age of one year, then the complete date or a minimum of the month and year is necessary to enable accurate age calculations - for example, if used to drive decision support. Data captured/imported as "Age at time of resolution" should be converted to a date using the subject's date of birth.
New York Heart Association functional classificationNew York Heart Association functional classification: A simple method of classifying the extent of heart failure, as defined by the New York Heart Association.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Functional capacityFunctional capacity: Assessment of heart failure based on how a patient with cardiac disease feels during physical activity.
Class III and the Class III subtypes, IIIa and IIIb, are intended to be mutually exclusive but are included in this internal code set for completeness. Within a template either the Class III alone or both of the subtypes, IIIa and IIIb, should be set to inactive.
  • Class I 
  • Class II 
  • Class III 
  • Class IV 
Pulmonary comobiditiesPulmonary comobidities: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Asthma
  • COPD
  • Other chronic pulmonary diseases
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown 
Neurological comorbiditiesNeurological comorbidities: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Hemiplegia
  • Dementia
  • Cerebrovascular disease, stroke, TIA
  • Motoneuron diseases
  • Movement disorder
  • Multiple sclerosis
  • Myasthenia gravis
  • Neuromyelitis optica spectrum disorder (NMOSD)
  • Other neurological autoimmune diseases
  • Other prior neurological diagnosis
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown 
Hemato/oncological comorbiditiesHemato/oncological comorbidities: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Leukemia
  • Lymphoma
  • Solid tumor
  • Solid tumor, metastasized
  • Stem cell transplantation
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown 
Other comorbiditiesOther comorbidities: An individual- or self-reported questionnaire screening for symptoms and signs.
Data
Any eventAny event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time.
Data
Specific symptom/signSpecific symptom/sign: Grouping of data elements related to screening for a single symptom or sign.
Symptom or sign nameSymptom or sign name: Name of the symptom or sign being screened.
  • Connective tissue disase
  • Peptic ulcer disease
  • Chronic liver disease
  • Liver cirrhosis
  • Diabetes, no end-organ damage
  • Diabetes, with end-organ damage
  • Acute kidney injury
  • Chronic kidney disease
  • On dialysis
  • Organ transplantation
  • Rheumatic disease
  • HIV/AIDS
Presence?Presence?: Presence of the symptom or sign.
  • Present 
  • Absent 
  • Unknown